Efficacy of novel azole compounds (ATTAF-1 and ATTAF-2) against Candida albicans in a murine model of invasive Candidiasis

被引：0

作者：

Badali, Hamid ^{[1
,2
]}

Fakhim, Hamed ^{[3
]}

Vaezi, Afsane ^{[4
]}

Emami, Saeed ^{[5
,6
]}

Nasiry, Davood ^{[5
,6
]}

Hashemi, Seyedeh Mahdieh ^{[5
,6
]}

机构：

[1] Univ Texas San Antonio, San Antonio, TX USA

[2] Mazandaran Univ Med Sci, Invas Fungi Res Ctr, Communicable Dis Inst, Sari, Iran

[3] Isfahan Univ Med Sci, Infect Dis & Trop Med Res Ctr, Esfahan, Iran

[4] Iran Univ Med Sci, Sch Allied Med Sci, Dept Med Lab Sci, Tehran, Iran

[5] Mazandaran Univ Med Sci, Dept Med Chem, Fac Pharm, Sari, Iran

[6] Mazandaran Univ Med Sci, Pharmaceut Sci Res Ctr, Fac Pharm, Sari, Iran

来源：

MEDICAL MYCOLOGY | 2022年 / 60卷 / SUPP 1期

关键词：

D O I：

10.1093/mmy/myac072.P032

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

P032

引用

页码：51 / 51

页数：1

共 48 条

[21] Efficacy of Novel Schiff base Derivatives as Antifungal Compounds in Combination with Approved Drugs Against Candida Albicans
Malik, Manzoor Ahmad
Lone, Shabir Ahmad
Gull, Parveez
Dar, Ovas Ahmad
Wani, Molumnad Younus
Ahmad, Aijaz
Hashmi, Athar Adil
[J]. MEDICINAL CHEMISTRY, 2019, 15 (06) : 648 - 658
[22] The in vitro and in vivo efficacy of fluconazole in combination with farnesol against Candida albicans isolates using a murine vulvovaginitis model
Aliz Bozó
Marianna Domán
László Majoros
Gábor Kardos
István Varga
Renátó Kovács
[J]. Journal of Microbiology, 2016, 54 : 753 - 760
[23] The in vitro and in vivo efficacy of fluconazole in combination with farnesol against Candida albicans isolates using a murine vulvovaginitis model
Bozo, Aliz
Doman, Marianna
Majoros, Laszlo
Kardos, Gabor
Varga, Istvan
Kovacs, Renato
[J]. JOURNAL OF MICROBIOLOGY, 2016, 54 (11) : 753 - 760
[24] Variation in fluconazole efficacy for Candida albicans strains sequentially isolated from oral cavities of patients with AIDS in an experimental murine candidiasis model
Barchiesi, F
Najvar, LK
Luther, MF
Scalise, G
Rinaldi, MG
Graybill, JR
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (05) : 1317 - 1320
[25] The prophylactic effects of monoclonal antibodies targeting the cell wall Pmt4 protein epitopes of Candida albicans in a murine model of invasive candidiasis
Wang, Xiaojuan
Liu, Peng
Jiang, Yuanying
Han, Bing
Yan, Lan
[J]. FRONTIERS IN MICROBIOLOGY, 2022, 13
[26] Influence of Glucose on Candida albicans and the Relevance of the Complement FH-Binding Molecule Hgt1 in a Murine Model of Candidiasis
Harpf, Verena
Kenno, Samyr
Rambach, Guenter
Fleischer, Verena
Parth, Nadia
Weichenberger, Christian X.
Garred, Peter
Huber, Silke
Lass-Floerl, Cornelia
Speth, Cornelia
Wuerzner, Reinhard
[J]. ANTIBIOTICS-BASEL, 2022, 11 (02):
[27] Killing Rates of Caspofungin in 50 Percent Serum Correlate with Caspofungin Efficacy Against Candida albicans in a Neutropenic Murine Model
Doman, Marianna
Kovacs, Renato
Kardos, Gabor
Gesztelyi, Rudolf
Juhasz, Bela
Bozo, Aliz
Kardos, Tamas
Saleh, Qasem
Majoros, Laszla
[J]. CURRENT DRUG DELIVERY, 2016, 13 (02) : 255 - 264
[28] Toll-like receptor 2 is dispensable for acquired host immune resistance to Candida albicans in a murine model of disseminated candidiasis
Villamón, E
Gozalbo, D
Roig, P
O'Connor, JE
Ferrandiz, ML
Fradelizi, D
Gil, ML
[J]. MICROBES AND INFECTION, 2004, 6 (06) : 542 - 548
[29] Efficacy of humanized single large doses of caspofungin on the lethality and fungal tissue burden in a deeply neutropenic murine model against Candida albicans and Candida dubliniensis
Prepost, Eszter
Toth, Zoltan
Perlin, David S.
Gesztelyi, Rudolf
Kardos, Gabor
Kovacs, Renato
Nagy, Fruzsina
Forgacs, Lajos
Majoros, Laszlo
[J]. INFECTION AND DRUG RESISTANCE, 2019, 12 : 1805 - 1814
[30] Efficacy of a Genetically Engineered Candida albicans tet-NRG1 Strain as an Experimental Live Attenuated Vaccine against Hematogenously Disseminated Candidiasis
Saville, Stephen P.
Lazzell, Anna L.
Chaturvedi, Ashok K.
Monteagudo, Carlos
Lopez-Ribot, Jose L.
[J]. CLINICAL AND VACCINE IMMUNOLOGY, 2009, 16 (03) : 430 - 432

← 1 2 3 4 5 →